News

Five deaths and hundreds of illnesses 'linked to weight-loss jabs'
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Managed Healthcare Executive58m
The Direct-To-Consumer Drug Gambit and Debate
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ...